Our Services

At Nexus CMC Advisors, we provide a comprehensive range of Chemistry, Manufacturing, and Controls (CMC) consulting services designed to support lean regulatory CMC teams engaged in the clinical stages of small molecule, peptide, or oligonucleotide drug development. Whether you are advancing a novel therapeutic through early clinical trials (IND) or preparing for a marketing application submission (NDA/BLA), our expert team offers tailored regulatory solutions to ensure compliance with U.S. FDA requirements.

Our deep expertise in synthetic peptide, oligonucleotide, and small molecule therapeutics, combined with a focus on quality, allows us to address even the most complex challenges. From strategic regulatory planning to managing compliance audits, we are committed to guiding your product through each phase of development, helping you bring innovative treatments to market efficiently and successfully.

Explore our specialized services below to learn more about how we can support your CMC needs.